Exicure (XCUR) Share-based Compensation Growth (1y) (2017 - 2025)
Exicure (XCUR) Share-based Compensation Growth (1y) (2017 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Stock Comp. Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
719,706.53 Bn |
719,706.50 Bn |
- |
- |
| 2 |
Belite Bio |
55,800.00 Bn |
55,800.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
18,182.30 Bn |
18,182.29 Bn |
- |
- |
| 4 |
Legend Biotech |
3,154.00 Bn |
3,153.71 Bn |
242.10 Mn |
- |
| 5 |
Akari Therapeutics |
1,844.30 Bn |
1,844.29 Bn |
- |
-69.95% |
| 6 |
Evaxion A |
1,567.96 Bn |
1,567.94 Bn |
- |
- |
| 7 |
Psyence Biomedical |
251.43 Bn |
251.42 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
112.56 Bn |
105.31 Bn |
2.59 Bn |
0.18% |
| 9 |
Abivax |
94.37 Bn |
94.37 Bn |
- |
- |
| 10 |
Exicure |
19.38 Mn |
16.77 Mn |
- |
- |
| Date | Value |
|---|
| Dec 31, 2025 |
-83.33% |
| Jun 30, 2025 |
-83.33% |
| Dec 31, 2024 |
-71.43% |
| Sep 30, 2024 |
-90.00% |
| Jun 30, 2024 |
-99.38% |
| Mar 31, 2024 |
-98.38% |
| Dec 31, 2023 |
-90.79% |
| Sep 30, 2023 |
-82.88% |
| Jun 30, 2023 |
91.12% |
| Mar 31, 2023 |
-9.94% |
| Dec 31, 2022 |
-70.35% |
| Sep 30, 2022 |
-67.15% |
| Jun 30, 2022 |
-33.64% |
| Mar 31, 2022 |
-33.85% |
| Dec 31, 2021 |
32.36% |
| Sep 30, 2021 |
43.85% |
| Jun 30, 2021 |
40.44% |
| Mar 31, 2021 |
17.23% |
| Dec 31, 2020 |
44.89% |
| Sep 30, 2020 |
20.94% |
